HomeNewsVideos

Pyridam Farma channels loan to Holi Pharma

05 May 2022 06:38

JAKARTA – PT Pyridam Farma Tbk (PYFA) distributes a credit facility of IDR 18 billion to solidify the capital expenditure budget of its subsidiary, PT Holi Pharma. Nadia Miranty Verdiana, Corporate Secretary of Pyridam Farma, relayed the news of this transaction in the information disclosure quoted Thursday (5/5).

“The credit agreement was signed last week (28/4) to fund operational needs, capital expenditure, and the repayment of loans received by Holi Pharma,” Verdiana revealed.

According to Verdiana, this transaction has no conflict of interest in respect to the Financial Services Authority Regulations (POJK) No.42/2020. This loan is less than 20% of the company’s equity recorded in September 2021 of IDR 182.95 billion.

In September 2021, the company reported cash and cash equivalents of IDR 42.29 billion, current assets of IDR 248.34 billion, and short-term liabilities of IDR 115.04 billion. (LK/ZH)

© 2024 - IDN Financials - All Rights Reserved.